The association between proton-pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy.
Chun-Ting HoChia-Chu FuElise Chia-Hui TanWei-Yu KaoPei-Chang LeeYi-Hsiang HuangTeh-Ia HuoMing-Chih HouJaw-Ching WuChien-Wei SuPublished in: Journal of gastroenterology and hepatology (2024)
Long-term PPI use (≥ 180 cDDD) may be associated with a better RFS in HCC patients after hepatectomy.